• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对大量临床分期为T1期肾肿块患者的初步观察:来自全州范围内MUSIC-KIDNEY协作研究的结果

Initial Observation of a Large Proportion of Patients Presenting with Clinical Stage T1 Renal Masses: Results from the MUSIC-KIDNEY Statewide Collaborative.

作者信息

Patel Amit K, Rogers Craig G, Johnson Anna, Noyes Sabrina L, Qi Ji, Miller David, Shervish Edward, Stockton Benjamin, Lane Brian R

机构信息

Henry Ford Health System, Detroit, MI, USA.

Department of Urology, Michigan Medicine, Ann Arbor, MI, USA.

出版信息

Eur Urol Open Sci. 2020 Dec 4;23:13-19. doi: 10.1016/j.euros.2020.11.002. eCollection 2021 Jan.

DOI:10.1016/j.euros.2020.11.002
PMID:34337485
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8317780/
Abstract

BACKGROUND

While surgical excision remains the principal management strategy for clinical T1 renal masses (cT1RMs), the rates of noninterventional approaches are not well known. Most single-institution and population-based series suggest rates below 10%.

OBJECTIVE

To evaluate the use of observation for newly diagnosed cT1RM patients in academic and community-based practices across a statewide collaborative.

DESIGN SETTING AND PARTICIPANTS

The Michigan Urological Surgery Improvement Collaborative-Kidney mass: Identifying and Defining Necessary Evaluation and therapY (MUSIC-KIDNEY) commenced data collection in September 2017 by recording clinical, radiographic, pathologic, and short-term follow-up data for cT1RM patients at 13 diverse practices. Patients with complete data were assessed at >90 d after initial evaluation as to whether observation or treatment was performed.

OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS

Relationships with outcomes were analyzed using multivariable logistic regression, chi-square test, and Wilcoxon rank-sum test.

RESULTS AND LIMITATIONS

Out of 965 patients, observation was employed in 48% ( = 459), with practice-level rates ranging from 0% to 68%. Patients managed with observation (vs treatment) were significantly older (71.2 vs 62.8 yr,  <  0.0001) and had smaller tumors (2.3 vs 3.4 cm,  <  0.0001). Observation was used for 53.5% of cT1a renal masses, for 29.9% of cT1b renal masses, and for 42.5%, 53.7%, and 63.9% of radiographically solid, Bosniak III-IV cystic, and indeterminate cT1RMs, respectively. Factors significantly associated with observation in multivariable analysis included lesion type (Bosniak III-IV vs solid,  =  0.017), tumor stage (cT1a vs cT1b,  <  0.001), and higher age ( <  0.001). A short duration of follow-up limits the assessment of longer-term patient management.

CONCLUSIONS

Noninterventional management of cT1RMs is common across the MUSIC-KIDNEY collaborative, with wide variability across practices. Factors associated with observation were advanced age, smaller tumor size, and cystic tumor type. Durability of the initial decision for observation (delayed intervention vs active surveillance vs less active surveillance) will be a focus of subsequent study.

PATIENT SUMMARY

The Michigan Urological Surgery Improvement Collaborative: Kidney mass: Identifying and Defining Necessary Evaluation and therapY (MUSIC-KIDNEY) quality improvement collaborative assessed the current utilization of initial observation of a renal mass ≤7 cm across a diverse group of urology practices and found it to be used in 48% of patients. We found that the factors predicting observation were advanced age, smaller tumor size, and cystic tumor type.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b24d/8317780/bc6028adb582/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b24d/8317780/2fa9ebbce2ed/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b24d/8317780/bc6028adb582/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b24d/8317780/2fa9ebbce2ed/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b24d/8317780/bc6028adb582/gr2.jpg

背景

虽然手术切除仍然是临床T1期肾肿块(cT1RMs)的主要治疗策略,但非介入性治疗方法的使用率尚不清楚。大多数单机构和基于人群的系列研究表明,其使用率低于10%。

目的

评估在全州范围内的学术和社区医疗机构中,对新诊断的cT1RM患者采用观察等待治疗的情况。

设计、地点和参与者:密歇根泌尿外科手术改进协作组-肾肿块:识别和定义必要的评估与治疗(MUSIC-KIDNEY)于2017年9月开始收集数据,记录了13个不同医疗机构中cT1RM患者的临床、影像学、病理和短期随访数据。对有完整数据的患者在初次评估后>90天进行评估,以确定是否进行了观察等待或治疗。

结局测量和统计分析

使用多变量逻辑回归、卡方检验和Wilcoxon秩和检验分析与结局的关系。

结果与局限性

在965例患者中,48%(n = 459)采用了观察等待治疗,各医疗机构的使用率从0%到68%不等。采用观察等待治疗(与接受治疗相比)的患者年龄显著更大(71.2岁对62.8岁,P < 0.0001),且肿瘤更小(2.3 cm对3.4 cm,P < 0.0001)。53.5%的cT1a期肾肿块、29.9%的cT1b期肾肿块以及分别42.5%、53.7%和63.9%的影像学表现为实性、Bosniak III-IV级囊性和不确定的cT1RMs采用了观察等待治疗。多变量分析中与观察等待治疗显著相关的因素包括病变类型(Bosniak III-IV级囊性对实性,P = 0.017)、肿瘤分期(cT1a对cT1b,P < 0.001)以及年龄较大(P < 0.001)。随访时间较短限制了对患者长期管理的评估。

结论

在MUSIC-KIDNEY协作组中,cT1RMs的非介入性管理很常见,各医疗机构之间存在很大差异。与观察等待治疗相关的因素包括年龄较大、肿瘤较小以及囊性肿瘤类型。观察等待治疗初始决策的持久性(延迟干预与主动监测与不太积极的监测)将是后续研究的重点。

患者总结

密歇根泌尿外科手术改进协作组:肾肿块:识别和定义必要的评估与治疗(MUSIC-KIDNEY)质量改进协作组评估了不同泌尿外科医疗机构中对≤7 cm肾肿块进行初始观察等待治疗的当前使用率,发现48%的患者采用了该方法。我们发现预测观察等待治疗的因素是年龄较大、肿瘤较小以及囊性肿瘤类型。

相似文献

1
Initial Observation of a Large Proportion of Patients Presenting with Clinical Stage T1 Renal Masses: Results from the MUSIC-KIDNEY Statewide Collaborative.对大量临床分期为T1期肾肿块患者的初步观察:来自全州范围内MUSIC-KIDNEY协作研究的结果
Eur Urol Open Sci. 2020 Dec 4;23:13-19. doi: 10.1016/j.euros.2020.11.002. eCollection 2021 Jan.
2
Utilization of Renal Mass Biopsy for T1 Renal Lesions across Michigan: Results from MUSIC-KIDNEY, A Statewide Quality Improvement Collaborative.密歇根州T1期肾病变肾肿块活检的应用:来自全州质量改进协作项目MUSIC-KIDNEY的结果
Eur Urol Open Sci. 2021 Jun 24;30:37-43. doi: 10.1016/j.euros.2021.06.004. eCollection 2021 Aug.
3
Quality of Care for Renal Masses: The Michigan Urological Surgery Improvement Collaborative-Kidney Mass: Identifying & Defining Necessary Evaluation & Therapy (MUSIC-KIDNEY).肾肿物的医疗质量:密歇根泌尿外科手术改进协作组-肾脏肿物:识别与界定必要的评估及治疗(MUSIC-KIDNEY)
Urol Pract. 2020 Nov;7(6):507-514. doi: 10.1097/UPJ.0000000000000130. Epub 2020 Jan 8.
4
Guideline Compliance Regarding Chest Imaging of Suspicious cT1 Renal Masses in MUSIC-KIDNEY.关于 MUSIC-KIDNEY 中可疑 cT1 肾肿块的胸部成像的指南依从性。
Urol Pract. 2023 Jul;10(4):328-333. doi: 10.1097/UPJ.0000000000000408. Epub 2023 Apr 7.
5
A Statewide Quality Improvement Collaborative's Adherence to the 2017 American Urological Association Guidelines Regarding Initial Evaluation of Patients With Clinical T1 Renal Masses.一项全州范围的质量改进合作对 2017 年美国泌尿外科学会关于临床 T1 期肾肿瘤患者初始评估指南的遵循情况。
Urology. 2021 Dec;158:117-124. doi: 10.1016/j.urology.2021.08.036. Epub 2021 Sep 6.
6
Practice-Level Variation in Opioid-Free Discharge Following Surgery for T1 Renal Masses: A MUSIC-KIDNEY Analysis.T1期肾肿瘤手术后无阿片类药物出院的实践水平差异:一项MUSIC-肾脏分析
Urol Pract. 2024 Jan;11(1):126-132. doi: 10.1097/UPJ.0000000000000478. Epub 2023 Nov 21.
7
Initial Management of Indeterminate Renal Lesions in a Statewide Collaborative: A MUSIC-KIDNEY Analysis.全州协作中不确定肾脏病变的初始管理:MUSIC-KIDNEY 分析。
J Urol. 2023 Jul;210(1):79-87. doi: 10.1097/JU.0000000000003433. Epub 2023 Mar 22.
8
Partial nephrectomy should be classified as an inpatient procedure: Results from a statewide quality improvement collaborative.部分肾切除术应归类为住院手术:一项全州质量改进协作项目的结果
Urol Oncol. 2021 Apr;39(4):239.e9-239.e16. doi: 10.1016/j.urolonc.2021.01.001. Epub 2021 Jan 21.
9
Robot-assisted partial nephrectomy for large renal masses: a multi-institutional series.机器人辅助部分肾切除术治疗大体积肾肿瘤:多机构系列研究。
BJU Int. 2018 Jun;121(6):908-915. doi: 10.1111/bju.14139. Epub 2018 Mar 1.
10
Pathological and Clinical Outcomes in a Large Surveillance and Intervention Cohort of Radiographically Cystic Renal Masses.大型影像学囊性肾肿物监测与干预队列中的病理及临床结果
J Urol. 2023 Apr;209(4):686-693. doi: 10.1097/JU.0000000000003158. Epub 2023 Jan 11.

引用本文的文献

1
Durability of Active Surveillance for Localized Renal Masses: 3-year Outcomes in the Michigan Urological Surgery Improvement Collaborative.局限性肾肿块主动监测的耐久性:密歇根泌尿外科手术改进协作组的3年结果
Eur Urol Open Sci. 2025 Mar 26;75:11-19. doi: 10.1016/j.euros.2025.02.005. eCollection 2025 May.
2
Tumour size is associated with growth rates of >0.5 cm/year and delayed intervention in small renal masses in patients on active surveillance.肿瘤大小与每年生长速度超过0.5厘米相关,且对于接受主动监测的小肾肿块患者,干预延迟。
BJU Int. 2025 May;135(5):860-868. doi: 10.1111/bju.16651. Epub 2025 Jan 28.
3
2022 WUOF/SIU International Consultation on Urological Diseases: Active Surveillance for Small Renal Masses.

本文引用的文献

1
Quality of Care for Renal Masses: The Michigan Urological Surgery Improvement Collaborative-Kidney Mass: Identifying & Defining Necessary Evaluation & Therapy (MUSIC-KIDNEY).肾肿物的医疗质量:密歇根泌尿外科手术改进协作组-肾脏肿物:识别与界定必要的评估及治疗(MUSIC-KIDNEY)
Urol Pract. 2020 Nov;7(6):507-514. doi: 10.1097/UPJ.0000000000000130. Epub 2020 Jan 8.
2
Extended Duration of Active Surveillance of Small Renal Masses: A Prospective Cohort Study.小肾肿瘤主动监测的延长时间:一项前瞻性队列研究。
J Urol. 2019 Jul;202(1):57-61. doi: 10.1097/JU.0000000000000075. Epub 2019 Jun 7.
3
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update.
2022年世界泌尿外科肿瘤联合会/国际泌尿外科学会国际泌尿外科疾病咨询会议:小肾肿瘤的主动监测
Soc Int Urol J. 2022 Nov;3(6):424-436. doi: 10.48083/oses5540.
4
The evolving management of small renal masses.小肾肿瘤的不断演变的治疗策略。
Nat Rev Urol. 2024 Jul;21(7):406-421. doi: 10.1038/s41585-023-00848-6. Epub 2024 Feb 16.
5
Renal cancer: From current evidence to future perspectives.肾癌:从当前证据到未来展望
Asian J Urol. 2022 Jul;9(3):199-200. doi: 10.1016/j.ajur.2022.05.001. Epub 2022 May 30.
6
Utilization of Renal Mass Biopsy for T1 Renal Lesions across Michigan: Results from MUSIC-KIDNEY, A Statewide Quality Improvement Collaborative.密歇根州T1期肾病变肾肿块活检的应用:来自全州质量改进协作项目MUSIC-KIDNEY的结果
Eur Urol Open Sci. 2021 Jun 24;30:37-43. doi: 10.1016/j.euros.2021.06.004. eCollection 2021 Aug.
7
Contrast-enhanced ultrasound (CEUS) imaging for active surveillance of small renal masses.对比增强超声(CEUS)成像用于小肾脏肿块的主动监测。
World J Urol. 2021 Aug;39(8):2853-2860. doi: 10.1007/s00345-021-03589-6. Epub 2021 Jan 22.
欧洲泌尿外科学会肾癌指南:2019 年更新版。
Eur Urol. 2019 May;75(5):799-810. doi: 10.1016/j.eururo.2019.02.011. Epub 2019 Feb 23.
4
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
5
Determinants of Active Surveillance in Patients With Small Renal Masses.小肾肿块患者主动监测的决定因素
Urology. 2019 Jan;123:167-173. doi: 10.1016/j.urology.2018.07.021. Epub 2018 Jul 27.
6
Is Routine Renal Tumor Biopsy Associated with Lower Rates of Benign Histology following Nephrectomy for Small Renal Masses?肾肿瘤常规活检与小肾肿瘤切除术后良性组织学比例降低有关吗?
J Urol. 2018 Oct;200(4):731-736. doi: 10.1016/j.juro.2018.04.015. Epub 2018 Apr 11.
7
Natural History of Complex Renal Cysts: Clinical Evidence Supporting Active Surveillance.复杂肾囊肿的自然病史:支持主动监测的临床证据。
J Urol. 2018 Mar;199(3):633-640. doi: 10.1016/j.juro.2017.09.078. Epub 2017 Sep 20.
8
Renal Mass and Localized Renal Cancer: AUA Guideline.肾脏肿块和局限性肾细胞癌:AUA 指南。
J Urol. 2017 Sep;198(3):520-529. doi: 10.1016/j.juro.2017.04.100. Epub 2017 May 4.
9
Bosniak Classification for Complex Renal Cysts Reevaluated: A Systematic Review.Bosniak 分类法在复杂肾囊肿中的再评估:系统评价。
J Urol. 2017 Jul;198(1):12-21. doi: 10.1016/j.juro.2016.09.160. Epub 2017 Mar 9.
10
Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline Summary.小肾肿瘤的管理:美国临床肿瘤学会临床实践指南摘要
J Oncol Pract. 2017 Apr;13(4):276-278. doi: 10.1200/JOP.2016.019620. Epub 2017 Jan 24.